Cite
Yiğenoğlu TN, Başcı S, Şahin D, et al. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci. 2021;103237doi: 10.1016/j.transci.2021.103237.
Yiğenoğlu, T. N., Başcı, S., Şahin, D., Ulaş, T., Dal, M. S., Korkmaz, S., Hacıbekiroğlu, T., Namdaroğlu, S., Erkurt, M. A., Turgut, B., & Altuntaş, F. (2021). Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 103237. https://doi.org/10.1016/j.transci.2021.103237
Yiğenoğlu, Tuğçe Nur, et al. "Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients." Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis vol. (2021): 103237. doi: https://doi.org/10.1016/j.transci.2021.103237
Yiğenoğlu TN, Başcı S, Şahin D, Ulaş T, Dal MS, Korkmaz S, Hacıbekiroğlu T, Namdaroğlu S, Erkurt MA, Turgut B, Altuntaş F. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci. 2021 Aug 17;103237. doi: 10.1016/j.transci.2021.103237. Epub 2021 Aug 17. PMID: 34419356; PMCID: PMC8372452.
Copy
Download .nbib